Abstract
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
10.1016/j.eururo.2026.01.008
10.1016/j.eururo.2026.01.008
The prediction of cancer-specific mortality in T1 non-muscle-invasive bladder cancer: comparison of logistic regression and artificial neural network: a SEER population-based study
10.1007/s11255-023-03655-5 · 2023
Contemporary outcomes in non-muscle-invasive bladder cancer: a large European multicentre study
10.1111/bju.16780 · 2025
Final results of an EORTC-GU cancers group randomized study of maintenance bacillus Calmette-Guérin in intermediate- and high-risk Ta, T1 papillary carcinoma of the urinary bladder: one-third dose versus full dose and 1 year versus 3 years of maintenance
10.1016/j.eururo.2012.10.039 · 2013
Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials
10.1016/s0022-5347(05)64273-5 · 2002
No additional external references are available.